Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy

Bibliographic Details
Title:	Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Authors:	Mountzios, Giannis, de Toma, Alessandro, Economopoulou, Panagiota, Friedlaender, Alex, Banini, Marco, Lo Russo, Giuseppe, Baxevanos, Panagiotis, Roila, Fausto, Banna, Giuseppe Luigi, Christopoulou, Athina, Jimenez, Beatriz, Collazo-Lorduy, Ana, Linardou, Helena, Calles, Antonio, Galetta, Domenico, Addeo, Alfredo, Camerini, Andrea, Pizzutilo, Pamela, Kosmidis, Paris, Garassino, Marina Chiara, Proto, Claudia, Signorelli, Diego, Metro, Giulio
Source:	In Clinical Lung Cancer March 2021 22(2):e180-e192
Database:	ScienceDirect